Lincoln Pharmaceuticals Ltd Share Price (LINCOLN)
Check the latest share price of Lincoln Pharmaceuticals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Lincoln Pharmaceuticals Ltd Stock Performance
Get live Lincoln Pharmaceuticals Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹567.05Day's Price Range₹599.952 Week's Low
52 Week's High
₹49952-Week Price Range₹979.5
| Returns % | |
| 1 Month Return | -0.56 % |
| 3 Month Return | + 12.62 % |
| 1 Year Return | -4.82 % |
| 3 Year Return | + 94.44 % |
| 5 Year Return | + 260.36 % |
| Market Stats | |
| Previous Close | ₹597.40 |
| Open | ₹590.00 |
| Volume | 1.02L |
| Upper Circuit | ₹716.85 |
| Lower Circuit | ₹477.95 |
Lincoln Pharmaceuticals Ltd Fundamentals & Key Indicators
Check Lincoln Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,173.64 Cr
Return on Equity (ROE)
17.04
PE Ratio (TTM)
14.25
Return on capital employed (ROCE)
22.35
Industry PE ratio
57.39
Beta (LTM)
1.12
P/B Ratio
1.98
Dividend Yield
0.31
PEG Ratio
-2.61
Quarterly Earnings Growth YOY
-37.74
EPS (TTM)
46.58
Sector
Pharmaceuticals
Book Value
295.98
Technical Analysis
Bullish
View Technical Analysis
How to invest in Lincoln Pharmaceuticals Ltd?
Investing in Lincoln Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Lincoln Pharmaceuticals Ltd or LINCOLN on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Lincoln Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Lincoln Pharmaceuticals Ltd with just a few clicks!
Lincoln Pharmaceuticals Ltd Stock's Interest Amongst Investors
Lincoln Pharmaceuticals Ltd Valuation
Track how Lincoln Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (14.25x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (19.77x)
December 9, 2024
Today’s Price to Earnings Ratio: 14.25x
Lincoln Pharmaceuticals Ltd Financial Results
Get the annual and quarterly financial summary of Lincoln Pharmaceuticals Ltd, including revenue, profit, loss and more.
Indices Featuring Lincoln Pharmaceuticals Ltd Stock
Check stock indices that include Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Ltd Earnings Results
Lincoln Pharmaceuticals Ltd’s net profit fell -37.74% since last year same period to ₹11.58Cr in the Q4 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -44.25% fall in its net profits since last 3-months.
Read More about Earnings ResultsLincoln Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 - translating a dividend yield of 0.56%.
Read More about Dividends
Lincoln Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Lincoln Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.78% | 0.00 | |
| Foreign Institutions | 5% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 45.22% | 0.00 | |
| Others | 0% | 0.00 |
Lincoln Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Lincoln Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,173.64 | 52.07% | 0.50 | 93 | 580 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Lincoln Pharmaceuticals Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Aims for ₹1000 Crore Revenue - 27 May, 2025
Lincoln Pharmaceuticals targets ₹1000 crore in revenues over the next three years, driven by growth in cardiac, diabetic, derma, and ENT segments. The company plans to invest in new molecules and expand into export markets, including Canada, Australia, and Germany.Lincoln Pharma Reports Q4 Profit and Revenue Growth - 22 May, 2025
Lincoln Pharmaceuticals reported a net profit of Rs 11.62 crore for Q4 FY25, with revenue rising to Rs 161.30 crore. The company aims for Rs 750 crore revenue by FY26, focusing on lifestyle and chronic segments.
Insights on Lincoln Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 155.52 Cr → 161.3 Cr (in ₹), with an average increase of 3.6% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 45.06% to 45.22% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 36.6%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 50.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.78% of holdings in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 5.16% to 5.00% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 26.33 Cr → 11.58 Cr (in ₹), with an average decrease of 32.7% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 6 months, LINCOLN stock has moved down by -36.0%
About Lincoln Pharmaceuticals Ltd
Revenue: ₹168.18Cr as on March 2025 (Q4 FY25)
Net Profit: ₹11.58Cr as on March 2025 (Q4 FY25)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
| Organisation | Lincoln Pharmaceuticals Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Kishorbhai M Shah |
| E-voting on shares | Click here to vote |
Mutual Funds that own Lincoln Pharmaceuticals Ltd
Check out the Mutual Funds with significant holdings in Lincoln Pharmaceuticals Ltd.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Bandhan BSE Healthcare Index Fund Direct Growth | 0.04% |
FAQs
What is Lincoln Pharmaceuticals Ltd share price today?
Lincoln Pharmaceuticals Ltd share price today stands at ₹585.95, Open: ₹590, Previous Close: ₹597.4, High: ₹599.9, Low: ₹567.05, 52 Week High: ₹979.5, 52 Week Low: ₹499.
What is today's traded volume of Lincoln Pharmaceuticals Ltd?
Today's traded volume of Lincoln Pharmaceuticals Ltd is 1.02L. Which means that 1.02L shares of Lincoln Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
What is Lincoln Pharmaceuticals Ltd's market cap today?
Today's market capitalisation of Lincoln Pharmaceuticals Ltd is ₹1,173.64 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd’s 52 week high is ₹979.5 and 52 week low is ₹499. The current share price of Lincoln Pharmaceuticals Ltd is ₹585.95, which is -40.18% down from its 52 week high and 17.42% up from its 52 week low.